Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2025
Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic andiral Characteristics and Response to Dual and Extended Antiviral TherapyJessica S Little, Gregory E Edelstein, Zoe Swank, et al.
Transplantation Direct|July 22, 2026
Reactogenicity and Immunogenicity of Adjuvanted and Nonadjuvanted RSV Vaccines in Solid Organ Transplant RecipientsAlisse Hannaford, Elene Chamberlin, Zoe Swank, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2024
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important changeSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 17, 2021
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scaleSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US AdultsChristina A Rostad, Robert L Atmar, Emmanuel B Walter, et al.
Science (New York, N.Y.)|December 2, 2021
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domainKatherine G Nabel, Sarah A Clark, Sundaresh Shankar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2024
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled TrialsAmy C Sherman, Jessica Tuan, Valeria D Cantos, et al.
Head & Neck|January 13, 2019
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IVSusanne Singer, Cecilie Delphin Amdal, Eva Hammerlid, et al.
Open Forum Infectious Diseases|March 4, 2024
Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid LeukemiaJessica S Little, Cassie Coughlin, Candace Hsieh, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunityEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Pageof 30